Article
Weight, CYP3A5 Genotype, and Voriconazole Co-administration Influence Tacrolimus Initial Dosage in Pediatric Lung Transplantation Recipients with Low Hematocrit based on a Simulation Model.
Current pharmaceutical design - 1 Jan 2024
Hu Ke, Pan Jia-Jun, Qu Wen-Qian, He Su-Mei, Yang Yang, Shi Hao-Zhe, Zhang Yi-Jia, Chen Xiao, Wang Dong-Dong
Abstract excerpt
OBJECTIVE: The method of administering the initial doses of tacrolimus in recipients of pediatric lung transplantation, especially in patients with low hematocrit, is not clear. The present study aims to explore whether weight, CYP3A5 genotype, and voriconazole co-administration influence tacrolimus initial dosage in recipients of pediatric lung transplantation with low hematocrit based on safety and efficacy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
